Wednesday, January 13, 2021

"Moderna Hits The Jackpot With Covid-19 Vaccine"

 Pretty amazing for a company that had produced literally nothing prior to this coronavirus.

Korean biomedical review

Moderna said it has achieved sales of more than $11 billion from its Covid-19 vaccine this year and expects to show robust performances through next year.

 

image from article provided for the conference.

Moderna has recorded $11.7 billion in Covid-19 vaccine sales in the New Year. (Moderna)

"Backed by the vaccine's strong presence in the global community, the company has already signed advance purchase agreements (APAs) worth $11.7 billion with customer deposits of $2.81 billion for future supplies in 2021," Moderna CEO Stéphane Bancel said at the 2021 J.P. Morgan Healthcare Conference.

Vaccine's strong presence in the global community...


Bancel added that the company is making more APAs for this and next year.

Based on contracts signed with governments, Moderna predicts that it will supply vaccines of 600 million to 1 billion doses in 2021 and up to 1.2 billion doses in 2022. Bancel stressed the Covid-19 vaccine's success has drastically elevated Moderna's status as a vaccine developer.

"Moderna's Covid-19 vaccine has received approval (emergency use authorization, not approval) by regulators in more than 30 countries, including the U.S. Food and Drug Administration, European Medicines Agency, U.K.'s Medicines, and Healthcare Product Regulatory Agency, Health Canada, and Ministry of Health of Israel," Bancel said. "The company is also in the process of winning nods for its vaccine in Singapore, Switzerland, and the World Health Organization (WHO)."

To increase vaccine production and meet the global demand, the company has been working closely with key suppliers for raw materials to produce the vaccine since February last year, Bancel added.

During the presentation, the Moderna CEO also announced plans to expand indications for the vaccine.

"We are conducting researches of the Covid-19 vaccine on adolescents aged 12-17, and is planning a study of those for children aged 1-11," Bancel said. "Moderna will also start an additional one-year study on adults from July.

As the pandemic has raised the public's awareness of the need for more infectious disease vaccines, Moderna will accelerate its development of vaccines for other infectious diseases, such as flu, Zika, and respiratory syncytial virus.

"Moderna hopes to start the phase 3 clinical trials of cytomegalovirus this year," Bancel said. "The project could bring in an addition of revenue of $2 billion to $5 billion for the company."

출처 : KBR(http://www.koreabiomed.com)

4 comments:

  1. Penny,
    I am a long time fan.
    This video by David Martin makes an interesting case that Moderna is not even legally a vaccine. It is actually a gene therapy. And as you high light can only be used as a vaccine because of the emergency use authorization. https://www.youtube.com/watch?v=p_hwJkhNo9w&feature=share&fbclid=IwAR2r8MW2oYonAuWihQteuo0zW23Y9rgwp1xtnY8G9YQ1emzxVMtLEJDaFUQ.
    Also, wonderful sleuthing on the WHO shenanigans. Bravo.

    ReplyDelete
    Replies
    1. Thanks Christiana:

      I'll check the video out and you may have noticed I actually call this vaccine mRNA therapy. Because that's what it is.
      It's not a vaccine in the usual term, but, a manipulation/alteration of RNA

      Ribonucleic acid (RNA) is a polymeric molecule essential in various biological roles in coding, decoding, regulation and expression of genes. RNA and DNA are nucleic acids.

      Making it much more a gene therapy then a vaccination
      Long term affects- completely unknown

      Delete
  2. Doesn't Baal GateZ own a chunk of ModeRNA? Or, perhaps he owns a chunk of a chunk of a chunk. Or, maybe ModeRNA is part of his brainchild GAVI. Whatever.

    ReplyDelete
    Replies
    1. Hi GC- I'm not sure, but, wouldn't doubt it
      Where there is a vaccine, there is Bill Gates

      Delete

TROLLS &SPAM WILL BE DELETED WITHOUT HESITATION
KEEP IT RELEVANT. NO PERSONAL ATTACKS